Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Maas

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Urologic Oncology|April 4, 2026
Recurrence Patterns in Primary Urethral Carcinoma: Prognostic Impact of Inguinal and Pelvic LymphadenectomyRadion Garaz, Steffen Rausch, Cristian Mirvald, et al.
World Journal of Urology|October 31, 2018
Molecular predictors of response to PD-1/PD-L1 inhibition in urothelial cancerViktoria Stühler, Jan Moritz Maas, Jonas Bochem, et al.
World Journal of Urology|August 7, 2024
Patient-derived bladder cancer organoids show stable transcript expression along cultivationPhilipp Vollmer, Bastian Amend, Niklas Harland, et al.
World Journal of Urology|April 21, 2021
Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?Moritz Maas, Johannes Mischinger, Eva Compérat, et al.
Urologia Internationalis|June 20, 2024
Ex vivo Study of Partial Bladder Resection in a Porcine ModelAleksander Kielbik, Timo Hoffmans, Bastian Amend, et al.
Journal of Endourology|May 12, 2016
Flexible Vesiculovasoscopy Using a Microoptical System in a Human Cadaver Model: An Experimental Approach for Atraumatic Endoscopy of the Seminal TractDaniel Schlager, Moritz Maas, Simon Hein, et al.
Cells|September 8, 2023
A Protocol for Organoids from the Urine of Bladder Cancer PatientsSimon Walz, Paul Pollehne, Ruizhi Geng, et al.
Urologic Oncology|August 11, 2020
Prognostic impact of somatostatin receptor expression in advanced bladder cancerMoritz Maas, Lisa Mayer, Jörg Hennenlotter, et al.
Cancers|April 13, 2024
PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette-Guérin (BCG) TherapyMoritz Maas, Andreas Hilsendecker, Alexandra Pertoll, et al.
Disease Markers|August 18, 2018
Systemic Alterations of Wnt Inhibitors in Patients with Prostate Cancer and Bone MetastasesStefan Aufderklamm, Jörg Hennenlotter, Phillip Leidenberger, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Urologic Oncology|April 4, 2026
Recurrence Patterns in Primary Urethral Carcinoma: Prognostic Impact of Inguinal and Pelvic LymphadenectomyRadion Garaz, Steffen Rausch, Cristian Mirvald, et al.
World Journal of Urology|October 31, 2018
Molecular predictors of response to PD-1/PD-L1 inhibition in urothelial cancerViktoria Stühler, Jan Moritz Maas, Jonas Bochem, et al.
World Journal of Urology|August 7, 2024
Patient-derived bladder cancer organoids show stable transcript expression along cultivationPhilipp Vollmer, Bastian Amend, Niklas Harland, et al.
World Journal of Urology|April 21, 2021
Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?Moritz Maas, Johannes Mischinger, Eva Compérat, et al.
Urologia Internationalis|June 20, 2024
Ex vivo Study of Partial Bladder Resection in a Porcine ModelAleksander Kielbik, Timo Hoffmans, Bastian Amend, et al.
Journal of Endourology|May 12, 2016
Flexible Vesiculovasoscopy Using a Microoptical System in a Human Cadaver Model: An Experimental Approach for Atraumatic Endoscopy of the Seminal TractDaniel Schlager, Moritz Maas, Simon Hein, et al.
Cells|September 8, 2023
A Protocol for Organoids from the Urine of Bladder Cancer PatientsSimon Walz, Paul Pollehne, Ruizhi Geng, et al.
Urologic Oncology|August 11, 2020
Prognostic impact of somatostatin receptor expression in advanced bladder cancerMoritz Maas, Lisa Mayer, Jörg Hennenlotter, et al.
Cancers|April 13, 2024
PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette-Guérin (BCG) TherapyMoritz Maas, Andreas Hilsendecker, Alexandra Pertoll, et al.
Disease Markers|August 18, 2018
Systemic Alterations of Wnt Inhibitors in Patients with Prostate Cancer and Bone MetastasesStefan Aufderklamm, Jörg Hennenlotter, Phillip Leidenberger, et al.
Pageof 4